Stocks · NYSE · Healthcare · United States

TAK — Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TAK) is a healthcare stock listed on NYSE (United States). At the close of September 29, 2026 it traded at 18.51 (-2.06% on the day), +3.0% over one month, +16.1% over three months, +26.6% over twelve months. The InvestMuse composite score is +51 on a −100 to +100 scale, a bullish read that ranks #213 of about 1,221 assets. The strongest of its nine dimensions are Fundamentals (+66) and Trend (+57); the weakest is Sector edge (-10). Its volatility regime from the hidden Markov model is Calm. 12 news articles in the last 30 days carried an average tone of +0.33 (on −1 to +1).

Open the interactive read →Race TAK with $100k play money

The facts

Last close18.51 (September 29, 2026)
1 day / 1 month / 3 months / 12 months-2.06% / +3.0% / +16.1% / +26.6%
52-week range13.23 – 19.05
Composite score+51 / 100 · bullish view · rank #213
Volatility regime (HMM)Calm
Support levels14.00, 16.00, 19.00
Resistance levels24.00
Trailing P/E0.3
Market cap$51.4B

The nine dimensions

Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.

How this read is made

Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.

Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.